388 related articles for article (PubMed ID: 23322821)
1. Breast cancer stem cells: an update.
Iqbal J; Chong PY; Tan PH
J Clin Pathol; 2013 Jun; 66(6):485-90. PubMed ID: 23322821
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
Xia H; Hui KM
Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
[TBL] [Abstract][Full Text] [Related]
3. Breast-cancer stem cells-beyond semantics.
Badve S; Nakshatri H
Lancet Oncol; 2012 Jan; 13(1):e43-8. PubMed ID: 22225725
[TBL] [Abstract][Full Text] [Related]
4. Distribution of cancer stem cells in ductal invasive carcinoma of breast (review).
Gudadze M; Kankava K; Mariamidze A; Burkadze G
Georgian Med News; 2013 Sep; (222):44-50. PubMed ID: 24099814
[TBL] [Abstract][Full Text] [Related]
5. Recurrence and metastasis of breast cancer is influenced by ovarian hormone's effect on breast cancer stem cells.
Nandy SB; Gangwani L; Nahleh Z; Subramani R; Arumugam A; de la Rosa JM; Lakshmanaswamy R
Future Oncol; 2015; 11(6):983-95. PubMed ID: 25760978
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs and cancer stem cells: therapeutic approaches and future perspectives.
Leal JA; Lleonart ME
Cancer Lett; 2013 Sep; 338(1):174-83. PubMed ID: 22554710
[TBL] [Abstract][Full Text] [Related]
7. Insights into the cell of origin in breast cancer and breast cancer stem cells.
Lindeman GJ; Visvader JE
Asia Pac J Clin Oncol; 2010 Jun; 6(2):89-97. PubMed ID: 20565420
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer stem cells.
Vaiopoulos AG; Kostakis ID; Koutsilieris M; Papavassiliou AG
Stem Cells; 2012 Mar; 30(3):363-71. PubMed ID: 22232074
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer.
Tsang JY; Huang YH; Luo MH; Ni YB; Chan SK; Lui PC; Yu AM; Tan PH; Tse GM
Breast Cancer Res Treat; 2012 Nov; 136(2):407-17. PubMed ID: 23053657
[TBL] [Abstract][Full Text] [Related]
10. Cancer stem cells in breast cancer and metastasis.
Lawson JC; Blatch GL; Edkins AL
Breast Cancer Res Treat; 2009 Nov; 118(2):241-54. PubMed ID: 19731012
[TBL] [Abstract][Full Text] [Related]
11. Primary culture of breast cancer: a model system for epithelial-mesenchymal transition and cancer stem cells.
Nishikata T; Ishikawa M; Matsuyama T; Takamatsu K; Fukuhara T; Konishi Y
Anticancer Res; 2013 Jul; 33(7):2867-73. PubMed ID: 23780972
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.
Ricardo S; Vieira AF; Gerhard R; Leitão D; Pinto R; Cameselle-Teijeiro JF; Milanezi F; Schmitt F; Paredes J
J Clin Pathol; 2011 Nov; 64(11):937-46. PubMed ID: 21680574
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer stem cells and epithelial mesenchymal plasticity - Implications for chemoresistance.
Pinto CA; Widodo E; Waltham M; Thompson EW
Cancer Lett; 2013 Nov; 341(1):56-62. PubMed ID: 23830804
[TBL] [Abstract][Full Text] [Related]
14. Targeting IL-8 signalling to inhibit breast cancer stem cell activity.
Singh JK; Simões BM; Clarke RB; Bundred NJ
Expert Opin Ther Targets; 2013 Nov; 17(11):1235-41. PubMed ID: 24032691
[TBL] [Abstract][Full Text] [Related]
15. The hitchhikers guide to cancer stem cell theory: markers, pathways and therapy.
Fábián Á; Vereb G; Szöllősi J
Cytometry A; 2013 Jan; 83(1):62-71. PubMed ID: 22997049
[TBL] [Abstract][Full Text] [Related]
16. Expansion of breast cancer stem cells with fibrous scaffolds.
Feng S; Duan X; Lo PK; Liu S; Liu X; Chen H; Wang Q
Integr Biol (Camb); 2013 May; 5(5):768-77. PubMed ID: 23529778
[TBL] [Abstract][Full Text] [Related]
17. Reduction of the putative CD44+CD24- breast cancer stem cell population by targeting the polyamine metabolic pathway with PG11047.
Cirenajwis H; Smiljanic S; Honeth G; Hegardt C; Marton LJ; Oredsson SM
Anticancer Drugs; 2010 Nov; 21(10):897-906. PubMed ID: 20838207
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer stem cells: current advances and clinical implications.
Luo M; Clouthier SG; Deol Y; Liu S; Nagrath S; Azizi E; Wicha MS
Methods Mol Biol; 2015; 1293():1-49. PubMed ID: 26040679
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Wnt1 expression reduces the enrichment of cancer stem cells in a mouse model of breast cancer.
Choi AR; Park JR; Kim RJ; Kim SR; Cho SD; Jung JY; Nam JS
Biochem Biophys Res Commun; 2012 Aug; 425(2):436-42. PubMed ID: 22846569
[TBL] [Abstract][Full Text] [Related]
20. Molecular biology of breast cancer stem cells: potential clinical applications.
Nguyen NP; Almeida FS; Chi A; Nguyen LM; Cohen D; Karlsson U; Vinh-Hung V
Cancer Treat Rev; 2010 Oct; 36(6):485-91. PubMed ID: 20231058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
